Cytune Pharma, a biotechnology company owned by PPF Group, is responsible for the clinical development of SO-C101, SOTIO is a sponsor of the Phase 1 clinical trial.
Company Details
- Employees
- 2
- Founded
- 2007
- Address
- 3, Chemin Du Pressoir Chênaie, Nantes,pays De La Loire 44100,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cytunepharma.com
- HQ
- Nantes, Pays de la Loire
Cytune Pharma Questions
Cytune Pharma's website is http://www.cytunepharma.com
Cytune Pharma's LinkedIn profile is https://fr.linkedin.com/company/cytune-pharma
Cytune Pharma has
2 employees.
View email and phone details for 2
employees at Cytune Pharma.
Cytune Pharma's industry is
Biotechnology Research
Cytune Pharma's top competitors are
Ogd2 Pharma,
Pherecydes Pharma,
Leucocytop',
Mycérial,
Effimune,
Profilehit,
Scientex.eu,
Fastox Pharma Sa,
Miti²,
Biofragma Biotechnology.
Cytune Pharma's categories are Biotechnology Research
Cytune Pharma's founding year is 2007
